abstract |
A use of a pharmaceutical formulation for the preparation of a medicament, wherein the medicament is for the treatment of pancreatic cancer, and the pharmaceutical formulation comprises (Z)-butylidenephthalide ((Z)-butylidenephthalide) and is substantially absent ( E)-butylidenephthalide ((E)-butylidenephthalide). |